High-dose cytosine arabinoside: pharmacological and clinical aspects
- 1 January 1988
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 56 (1) , 1-11
- https://doi.org/10.1007/bf00321053
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Subacute pulmonary failure complicating therapy with high-dose ara-C in acute leukemiaCancer, 1985
- The use of intermediate dose cytosine arabinoside (ID Ara‐C) in the treatment of acute non‐lymphocytic leukaemia in relapseBritish Journal of Haematology, 1984
- Ocular toxicity from high-dose cytosine arabinosideCancer, 1983
- TREATMENT OF REFRACTORY ACUTE LEUKAEMIA WITH HIGH DOSE CYTOSINE ARABINOSIDEBritish Journal of Haematology, 1982
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Action of 1-β-d-Arabinofuranosylcytosine on mammalian tumor cells—1.: Incorporation into DNAPublished by Elsevier ,1972
- Erythrocytic nucleoside diphosphokinase. IV. Evidence for electrophoretic heterogeneityBiochemistry, 1971
- Effect of cytosine arabinoside 5′-triphosphate on mammalian DNA polymeraseBiochemical and Biophysical Research Communications, 1969
- Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemiaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1968
- Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine ArabinosideScience, 1967